VolitionRx Limited Finite-Lived Intangible Asset, Expected Amortization, Year One
VolitionRx Limited (VNRX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $21.38 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $21.38K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $21.55K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $21.43K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $20.28K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2026-06-30 | $21.38K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $21.55K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $21.43K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $20.28K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $20.30K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $20.75K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $20.75K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $5.19K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $16.06K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $12.89K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $23.89K 10-K · filed 2024-03-25 | |
| 2023-09-30 | $28.65K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $24.67K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $27.34K 10-Q · filed 2023-05-10 | |
| 2020-09-30 | $24.75K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $44.34K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $64.64K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $87.54K 10-K · filed 2020-02-20 | |
| 2019-09-30 | $17.92K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $42.77K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $63.77K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $89.08K 10-K · filed 2019-03-13 | |
| 2018-09-30 | $20.57K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $43.72K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $71.26K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $92.61K 10-K · filed 2018-03-01 | |
| 2016-12-31 | $26.32K 10-Q · filed 2017-11-09 | $82.75K 10-K · filed 2017-03-10 |
| 2016-09-30 | $21.86K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $43.35K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $66.30K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $85.38K 10-K · filed 2016-03-11 | |
| 2015-09-30 | $21.91K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $43.32K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $61.25K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $87.31K 10-K · filed 2015-03-18 | |
| 2014-09-30 | $22.72K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $48.40K 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $73.55K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $98.16K 10-K · filed 2014-03-28 | |
| 2013-09-30 | $28.53K 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $56.94K 10-Q · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |